Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $15,815 - $18,183
-80 Reduced 7.82%
943 $214,000
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $18,094 - $19,953
-90 Reduced 8.09%
1,023 $205,000
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $15,360 - $19,664
-75 Reduced 6.31%
1,113 $227,000
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $17,407 - $19,978
-67 Reduced 5.34%
1,188 $313,000
Q4 2021

Feb 11, 2022

SELL
$271.6 - $314.21 $21,456 - $24,822
-79 Reduced 5.92%
1,255 $394,000
Q2 2021

Aug 06, 2021

SELL
$251.87 - $278.14 $20,905 - $23,085
-83 Reduced 5.86%
1,334 $368,000
Q4 2020

Feb 12, 2021

SELL
$186.91 - $214.42 $39,064 - $44,813
-209 Reduced 12.85%
1,417 $288,000
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $17,371 - $20,935
-104 Reduced 6.01%
1,626 $305,000
Q2 2020

Aug 05, 2020

BUY
$113.31 - $182.44 $12,464 - $20,068
110 Added 6.79%
1,730 $287,000
Q4 2019

Feb 13, 2020

SELL
$163.48 - $173.61 $14,876 - $15,798
-91 Reduced 5.32%
1,620 $274,000
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $12,541 - $15,042
-87 Reduced 4.84%
1,711 $296,000
Q4 2018

Feb 12, 2019

SELL
$120.82 - $174.09 $17,156 - $24,720
-142 Reduced 7.32%
1,798 $227,000
Q2 2018

Aug 13, 2018

SELL
$160.33 - $189.41 $26,454 - $31,252
-165 Reduced 7.84%
1,940 $348,000
Q1 2018

May 15, 2018

SELL
$161.53 - $178.11 $22,937 - $25,291
-142 Reduced 6.32%
2,105 $340,000
Q4 2017

Feb 14, 2018

SELL
$147.99 - $163.95 $15,686 - $17,378
-106 Reduced 4.5%
2,247 $358,000
Q2 2017

Aug 15, 2017

BUY
N/A
2,353
2,353 $363,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.